Development of a 3-month implantable depot pellet of naltrexone for the treatment of opioid use disorder
Ended Cooperative Agreement Awarded Last action
- Award ID
- UG3DA047925
- Recipient
-
Biocorrx Inc. UEI M66BMLPTXSM1
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,674,268
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $2,831,838 | |
| Amendment | -$2,831,838 | |
| Amendment | $0 | |
| Amendment | $2,831,838 | |
| Original award | $2,842,430 |
Show all 13
Quick answers
Who received award UG3DA047925?
UG3DA047925 was awarded to Biocorrx Inc. by National Institute on Drug Abuse (National Institutes of Health) on February 1, 2019.
How much is award UG3DA047925 worth?
$5,674,268 has been obligated on UG3DA047925.
Which agency awarded UG3DA047925?
National Institute on Drug Abuse (National Institutes of Health) awarded UG3DA047925, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award